z-logo
open-access-imgOpen Access
Increased Prevalence of theGCM2Polymorphism, Y282D, in Primary Hyperparathyroidism: Analysis of Three Italian Cohorts
Author(s) -
Leonardo D’Agruma,
Michela Coco,
Vito Guarnieri,
Claudia Battista,
Lucie Canaff,
Antonio Stefano Salcuni,
Sabrina Corbetta,
Filomena Cetani,
Salvatore Minisola,
Iacopo Chiodini,
Cristina Eller-Vainicher,
Anna Spada,
Claudio Marcocci,
Giuseppe Guglielmi,
Michele Zini,
Rosanna Clemente,
Betty Wong,
Danilo de Martino,
Alfredo Scillitani,
Geoffrey N. Hendy,
David E.C. Cole
Publication year - 2014
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-2857
Subject(s) - primary hyperparathyroidism , cohort , transactivation , endocrinology , missense mutation , medicine , hyperparathyroidism , biology , gastroenterology , genetics , phenotype , gene , gene expression
Glial cells missing-2 (GCM2) is key for parathyroid gland organogenesis. Its persistent expression in the adult parathyroid raises the possibility that overactive forms play a role in the evolution of parathyroid hyperactivity or tumorigenesis. A GCM2 c.844T → G; p.Y282D missense variant has been described within a transactivation inhibitory domain (amino acids 263-352).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom